87 related articles for article (PubMed ID: 31773233)
1. Textural features of hypoxia PET predict survival in head and neck cancer during chemoradiotherapy.
Sörensen A; Carles M; Bunea H; Majerus L; Stoykow C; Nicolay NH; Wiedenmann NE; Vaupel P; Meyer PT; Grosu AL; Mix M
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1056-1064. PubMed ID: 31773233
[TBL] [Abstract][Full Text] [Related]
2. Predicting hypoxia status using a combination of contrast-enhanced computed tomography and [
Crispin-Ortuzar M; Apte A; Grkovski M; Oh JH; Lee NY; Schöder H; Humm JL; Deasy JO
Radiother Oncol; 2018 Apr; 127(1):36-42. PubMed ID: 29273260
[TBL] [Abstract][Full Text] [Related]
3.
Carles M; Fechter T; Grosu AL; Sörensen A; Thomann B; Stoian RG; Wiedenmann N; Rühle A; Zamboglou C; Ruf J; Martí-Bonmatí L; Baltas D; Mix M; Nicolay NH
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298663
[TBL] [Abstract][Full Text] [Related]
4. [
Puri T; Greenhalgh TA; Wilson JM; Franklin J; Wang LM; Strauss V; Cunningham C; Partridge M; Maughan T
EJNMMI Res; 2017 Sep; 7(1):78. PubMed ID: 28933018
[TBL] [Abstract][Full Text] [Related]
5. Comparison of patient stratification by computed tomography radiomics and hypoxia positron emission tomography in head-and-neck cancer radiotherapy.
Socarrás Fernández JA; Mönnich D; Leibfarth S; Welz S; Zwanenburg A; Leger S; Löck S; Pfannenberg C; La Fougère C; Reischl G; Baumann M; Zips D; Thorwarth D
Phys Imaging Radiat Oncol; 2020 Jul; 15():52-59. PubMed ID: 33043157
[TBL] [Abstract][Full Text] [Related]
6. The significance of partial volume effect on the estimation of hypoxic tumour volume with [
Kafkaletos A; Mix M; Sachpazidis I; Carles M; Rühle A; Ruf J; Grosu AL; Nicolay NH; Baltas D
EJNMMI Phys; 2024 May; 11(1):43. PubMed ID: 38722446
[TBL] [Abstract][Full Text] [Related]
7. Investigation of atovaquone-induced spatial changes in tumour hypoxia assessed by hypoxia PET/CT in non-small cell lung cancer patients.
Bourigault P; Skwarski M; Macpherson RE; Higgins GS; McGowan DR
EJNMMI Res; 2021 Dec; 11(1):130. PubMed ID: 34964932
[TBL] [Abstract][Full Text] [Related]
8. Oxygen-enhanced MRI MOLLI T1 mapping during chemoradiotherapy in anal squamous cell carcinoma.
Bluemke E; Bulte D; Bertrand A; George B; Cooke R; Chu KY; Durrant L; Goh V; Jacobs C; Ng SM; Strauss VY; Hawkins MA; Muirhead R
Clin Transl Radiat Oncol; 2020 May; 22():44-49. PubMed ID: 32211520
[TBL] [Abstract][Full Text] [Related]
9. Correlative analyses between tissue-based hypoxia biomarkers and hypoxia PET imaging in head and neck cancer patients during radiochemotherapy-results from a prospective trial.
Nicolay NH; Wiedenmann N; Mix M; Weber WA; Werner M; Grosu AL; Kayser G
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1046-1055. PubMed ID: 31811344
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive tumor decoding and phenotyping of cerebral gliomas utilizing multiparametric
Haubold J; Demircioglu A; Gratz M; Glas M; Wrede K; Sure U; Antoch G; Keyvani K; Nittka M; Kannengiesser S; Gulani V; Griswold M; Herrmann K; Forsting M; Nensa F; Umutlu L
Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1435-1445. PubMed ID: 31811342
[TBL] [Abstract][Full Text] [Related]
11. Radiomics of
Mu W; Tunali I; Gray JE; Qi J; Schabath MB; Gillies RJ
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1168-1182. PubMed ID: 31807885
[TBL] [Abstract][Full Text] [Related]
12. Potential Added Value of PET/CT Radiomics for Survival Prognostication beyond AJCC 8th Edition Staging in Oropharyngeal Squamous Cell Carcinoma.
Haider SP; Zeevi T; Baumeister P; Reichel C; Sharaf K; Forghani R; Kann BH; Judson BL; Prasad ML; Burtness B; Mahajan A; Payabvash S
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32635216
[TBL] [Abstract][Full Text] [Related]
13. Multi-Level Multi-Modality Fusion Radiomics: Application to PET and CT Imaging for Prognostication of Head and Neck Cancer.
Lv W; Ashrafinia S; Ma J; Lu L; Rahmim A
IEEE J Biomed Health Inform; 2020 Aug; 24(8):2268-2277. PubMed ID: 31804945
[TBL] [Abstract][Full Text] [Related]
14. Individualized discrimination of tumor recurrence from radiation necrosis in glioma patients using an integrated radiomics-based model.
Wang K; Qiao Z; Zhao X; Li X; Wang X; Wu T; Chen Z; Fan D; Chen Q; Ai L
Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1400-1411. PubMed ID: 31773234
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive decision support for NSCLC treatment using PET/CT radiomics.
Mu W; Jiang L; Zhang J; Shi Y; Gray JE; Tunali I; Gao C; Sun Y; Tian J; Zhao X; Sun X; Gillies RJ; Schabath MB
Nat Commun; 2020 Oct; 11(1):5228. PubMed ID: 33067442
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of FDG-PET/CT-Based Radiomics for the Characterization and Genetic Orientation of Pheochromocytomas Before Surgery.
Ansquer C; Drui D; Mirallié E; Renaudin-Autain K; Denis A; Gimenez-Roqueplo AP; Leux C; Toulgoat F; Kraeber-Bodéré F; Carlier T
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32859070
[TBL] [Abstract][Full Text] [Related]
17. Machine learning-based analysis of [
Cysouw MCF; Jansen BHE; van de Brug T; Oprea-Lager DE; Pfaehler E; de Vries BM; van Moorselaar RJA; Hoekstra OS; Vis AN; Boellaard R
Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):340-349. PubMed ID: 32737518
[TBL] [Abstract][Full Text] [Related]
18. Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma.
Nie P; Yang G; Wang N; Yan L; Miao W; Duan Y; Wang Y; Gong A; Zhao Y; Wu J; Zhang C; Wang M; Cui J; Yu M; Li D; Sun Y; Wang Y; Wang Z
Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):217-230. PubMed ID: 32451603
[TBL] [Abstract][Full Text] [Related]
19. [18F]FDG-PET/CT Radiomics for Prediction of Bone Marrow Involvement in Mantle Cell Lymphoma: A Retrospective Study in 97 Patients.
Mayerhoefer ME; Riedl CC; Kumar A; Dogan A; Gibbs P; Weber M; Staber PB; Huicochea Castellanos S; Schöder H
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32370121
[TBL] [Abstract][Full Text] [Related]
20. Effect of machine learning re-sampling techniques for imbalanced datasets in
Xie C; Du R; Ho JW; Pang HH; Chiu KW; Lee EY; Vardhanabhuti V
Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2826-2835. PubMed ID: 32253486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]